By Associate Professor Lise Lafferty

Journal articles

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Lafferty L; Smith K; Causer L; Andrewartha K; Whiley D; Badman SG; Donovan B; Anderson L; Tangey A; Mak D; Maher L; Shephard M; Guy R; Bastian L; Ward J; Kaldor J; Comerford C; Bushby T; Moore L; Gunathilake M; Johnson D; Gallant D, 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers and facilitators', Implementation Science Communications, 2, pp. 127, http://dx.doi.org/10.1186/s43058-021-00232-8

Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, 21, pp. 1503, http://dx.doi.org/10.1186/s12889-021-11554-6

Hill AO; Bavinton BR; Kaneko N; Lafferty L; Lyons A; Gilmour S; Armstrong G, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, 50, pp. 3103 - 3113, http://dx.doi.org/10.1007/s10508-021-02097-3

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', Plos One, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Camara H; Zhang Y; Lafferty L; Vallely A; Guy R; Kelly-Hanku A, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', Jmir Research Protocols, 9, http://dx.doi.org/10.2196/21093

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs Education Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Settumba SN; Shanahan M; Butler T; Schofield P; Lafferty L; Simpson P; Chambers G, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy, http://dx.doi.org/10.1007/s40258-019-00484-5

Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987

Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141

Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6

hilferty F; Lafferty L; valentine K; Cale J; Zmudski F, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, 5th edition, pp. 34 - 47, https://icpa.org/library/a-preview-of-the-advancing-corrections-journal-edition-5-2018/

Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030

Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562

Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627

Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, 4, pp. 9, http://dx.doi.org/10.1186/s40352-016-0040-z

Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040

Lafferty L; Chambers GM; Guthrie J; Butler T, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8

Back to profile page